Breaking News

Saturday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$95.69

-0.67 (-0.70%)

, AGIO

Agios Pharmaceuticals

$73.42

-1.085 (-1.46%)

04:55
09/15/18
09/15
04:55
09/15/18
04:55
Conference/Events
Society of Hematologic Oncology to hold annual meeting »

SOHO 2018: 6th Annual…

ABBV

AbbVie

$95.69

-0.67 (-0.70%)

AGIO

Agios Pharmaceuticals

$73.42

-1.085 (-1.46%)

ALXN

Alexion

$118.19

-0.84 (-0.71%)

AMGN

Amgen

$200.54

-2.4 (-1.18%)

AZN

AstraZeneca

$37.45

-0.17 (-0.45%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$60.69

-0.11 (-0.18%)

CELG

Celgene

$87.18

-1.57 (-1.77%)

DNA

Bought by RHHBY

$0.00

(0.00%)

EPZM

Epizyme

$10.15

-0.05 (-0.49%)

GILD

Gilead

$73.38

-0.73 (-0.99%)

INCY

Incyte

$68.10

0.63 (0.93%)

JAZZ

Jazz Pharmaceuticals

$163.05

-2.17 (-1.31%)

KPTI

Karyopharm

$18.71

-0.15 (-0.80%)

LOXO

Loxo Oncology

$163.97

-1.38 (-0.83%)

MRK

Merck

$69.98

-0.4 (-0.57%)

NVS

Novartis

$85.26

-0.05 (-0.06%)

PFE

Pfizer

$42.97

0.11 (0.26%)

SGEN

Seattle Genetics

$78.22

1.02 (1.32%)

SHPG

Shire

$177.31

4.93 (2.86%)

SNSS

Sunesis

$1.86

-0.08 (-4.12%)

TEVA

Teva

$22.84

0.63 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 16

    Sep

  • 18

    Sep

  • 18

    Sep

  • 20

    Sep

  • 20

    Sep

  • 23

    Sep

  • 26

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 20

    Dec

  • 21

    Dec

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

Friday
ABBV

AbbVie

$96.36

3.11 (3.34%)

, AGIO

Agios Pharmaceuticals

$74.50

0.33 (0.44%)

04:55
09/14/18
09/14
04:55
09/14/18
04:55
Conference/Events
Society of Hematologic Oncology to hold annual meeting »

SOHO 2018: 6th Annual…

ABBV

AbbVie

$96.36

3.11 (3.34%)

AGIO

Agios Pharmaceuticals

$74.50

0.33 (0.44%)

ALXN

Alexion

$119.03

0.8 (0.68%)

AMGN

Amgen

$202.94

3.44 (1.72%)

AZN

AstraZeneca

$37.62

-0.265 (-0.70%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$60.80

0.48 (0.80%)

CELG

Celgene

$88.75

1.95 (2.25%)

DNA

Bought by RHHBY

$0.00

(0.00%)

EPZM

Epizyme

$10.20

0.45 (4.62%)

GILD

Gilead

$74.11

0.7 (0.95%)

INCY

Incyte

$67.47

0.93 (1.40%)

JAZZ

Jazz Pharmaceuticals

$165.22

-0.64 (-0.39%)

KPTI

Karyopharm

$18.86

0.25 (1.34%)

LOXO

Loxo Oncology

$165.35

0.44 (0.27%)

MRK

Merck

$70.86

1.01 (1.45%)

NVS

Novartis

$85.31

0.88 (1.04%)

PFE

Pfizer

$42.86

0.46 (1.08%)

SGEN

Seattle Genetics

$77.20

0.19 (0.25%)

SHPG

Shire

$172.38

-0.39 (-0.23%)

SNSS

Sunesis

$1.94

-0.09 (-4.43%)

TEVA

Teva

$22.21

0.01 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 15

    Sep

  • 16

    Sep

  • 18

    Sep

  • 18

    Sep

  • 20

    Sep

  • 20

    Sep

  • 23

    Sep

  • 26

    Sep

  • 02

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 20

    Dec

  • 21

    Dec

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

Thursday
ABBV

AbbVie

$93.25

0.05 (0.05%)

, AGIO

Agios Pharmaceuticals

$74.17

1.75 (2.42%)

04:55
09/13/18
09/13
04:55
09/13/18
04:55
Conference/Events
Society of Hematologic Oncology to hold annual meeting »

SOHO 2018: 6th Annual…

ABBV

AbbVie

$93.25

0.05 (0.05%)

AGIO

Agios Pharmaceuticals

$74.17

1.75 (2.42%)

ALXN

Alexion

$118.23

0.73 (0.62%)

AMGN

Amgen

$199.50

-0.01 (-0.01%)

AZN

AstraZeneca

$37.89

-0.095 (-0.25%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$60.32

-0.17 (-0.28%)

CELG

Celgene

$86.80

-0.41 (-0.47%)

DNA

Bought by RHHBY

$0.00

(0.00%)

EPZM

Epizyme

$9.75

0.1 (1.04%)

GILD

Gilead

$73.98

1.75 (2.42%)

INCY

Incyte

$66.54

-0.3 (-0.45%)

JAZZ

Jazz Pharmaceuticals

$165.86

0.12 (0.07%)

KPTI

Karyopharm

$18.61

-1.14 (-5.77%)

LOXO

Loxo Oncology

$164.91

-5.63 (-3.30%)

MRK

Merck

$69.85

0.76 (1.10%)

NVS

Novartis

$84.43

0.43 (0.51%)

PFE

Pfizer

$42.40

0.09 (0.21%)

SGEN

Seattle Genetics

$77.01

-1.38 (-1.76%)

SHPG

Shire

$172.77

2.6 (1.53%)

SNSS

Sunesis

$2.03

-0.01 (-0.49%)

TEVA

Teva

$22.20

0.32 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

  • 16

    Sep

  • 18

    Sep

  • 20

    Sep

  • 20

    Sep

  • 23

    Sep

  • 26

    Sep

  • 02

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 20

    Dec

  • 21

    Dec

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

Over a week ago
BMY

Bristol-Myers

$60.27

-0.22 (-0.36%)

, CELG

Celgene

$86.89

-0.32 (-0.37%)

15:38
09/12/18
09/12
15:38
09/12/18
15:38
Recommendations
Bristol-Myers, Celgene analyst commentary at Credit Suisse »

Bristol-Myers' TYK2…

BMY

Bristol-Myers

$60.27

-0.22 (-0.36%)

CELG

Celgene

$86.89

-0.32 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

ABBV

AbbVie

$93.56

0.36 (0.39%)

, AGIO

Agios Pharmaceuticals

$70.80

-1.62 (-2.24%)

10:39
09/12/18
09/12
10:39
09/12/18
10:39
Conference/Events
Society of Hematologic Oncology to hold annual meeting »

SOHO 2018: 6th Annual…

ABBV

AbbVie

$93.56

0.36 (0.39%)

AGIO

Agios Pharmaceuticals

$70.80

-1.62 (-2.24%)

ALXN

Alexion

$117.50

(0.00%)

AMGN

Amgen

$200.79

1.28 (0.64%)

AZN

AstraZeneca

$37.81

-0.17 (-0.45%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$60.48

-0.01 (-0.02%)

CELG

Celgene

$87.06

-0.15 (-0.17%)

DNA

Bought by RHHBY

$0.00

(0.00%)

EPZM

Epizyme

$9.70

0.05 (0.52%)

GILD

Gilead

$74.49

2.26 (3.13%)

INCY

Incyte

$65.79

-1.05 (-1.57%)

JAZZ

Jazz Pharmaceuticals

$164.81

-0.93 (-0.56%)

KPTI

Karyopharm

$19.26

-0.49 (-2.48%)

LOXO

Loxo Oncology

$168.08

-2.46 (-1.44%)

MRK

Merck

$69.73

0.64 (0.93%)

NVS

Novartis

$84.66

0.66 (0.79%)

PFE

Pfizer

$42.70

0.385 (0.91%)

SGEN

Seattle Genetics

$77.00

-1.39 (-1.77%)

SHPG

Shire

$171.30

1.13 (0.66%)

SNSS

Sunesis

$2.01

-0.03 (-1.47%)

TEVA

Teva

$22.08

0.2 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 16

    Sep

  • 20

    Sep

  • 20

    Sep

  • 23

    Sep

  • 26

    Sep

  • 02

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 20

    Dec

  • 21

    Dec

  • 16

    Feb

  • 18

    Feb

CELG

Celgene

$87.21

-1.95 (-2.19%)

07:40
09/12/18
09/12
07:40
09/12/18
07:40
Hot Stocks
Celgene says OTEZLA showed meaningful improvements in quality-of-life measures »

Celgene Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 29

    Oct

AMGN

Amgen

$203.42

7.06 (3.60%)

, BLUE

Bluebird Bio

$143.40

-8.1 (-5.35%)

14:26
09/10/18
09/10
14:26
09/10/18
14:26
Periodicals
Amgen presents threat to Bluebird Bio, Celgene in multiple myeloma, STAT says »

Early stage clinical data…

AMGN

Amgen

$203.42

7.06 (3.60%)

BLUE

Bluebird Bio

$143.40

-8.1 (-5.35%)

CELG

Celgene

$89.50

-0.97 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

  • 26

    Sep

  • 17

    Oct

  • 22

    Oct

  • 29

    Oct

  • 09

    Nov

  • 01

    Dec

AGIO

Agios Pharmaceuticals

$80.47

-3.3 (-3.94%)

, CELG

Celgene

$90.00

-2.2 (-2.39%)

11:35
09/06/18
09/06
11:35
09/06/18
11:35
Recommendations
Agios Pharmaceuticals, Celgene analyst commentary at Canaccord »

Agios ending AG-881…

AGIO

Agios Pharmaceuticals

$80.47

-3.3 (-3.94%)

CELG

Celgene

$90.00

-2.2 (-2.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 12

    Sep

  • 29

    Oct

AGIO

Agios Pharmaceuticals

$80.07

-3.7 (-4.42%)

, CELG

Celgene

$90.14

-2.06 (-2.23%)

11:29
09/06/18
09/06
11:29
09/06/18
11:29
Hot Stocks
Agios reports termination of collaboration pact with Celgene for AG-881 »

In a regulatory filing…

AGIO

Agios Pharmaceuticals

$80.07

-3.7 (-4.42%)

CELG

Celgene

$90.14

-2.06 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 12

    Sep

  • 29

    Oct

CGEN

Compugen

$3.90

-0.05 (-1.27%)

, CELG

Celgene

$92.19

-2.26 (-2.39%)

07:20
09/05/18
09/05
07:20
09/05/18
07:20
Hot Stocks
Compugen announces appointment of Jean-Pierre Bizzari to board of directors »

Compugen (CGEN) announced…

CGEN

Compugen

$3.90

-0.05 (-1.27%)

CELG

Celgene

$92.19

-2.26 (-2.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 12

    Sep

  • 29

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.